Tuesday, May 31, 2016
OV LiPlaCis™ - First Screened Breast Cancer Patient Dosed in First Prospective Study
… 1000 patients have had their tumors DRP-screened beforehand. The included patients … of cancer due to its documented efficacy in a number of tumour … ™, for Breast Cancer, Irofulven, developed from a fungus, for Prostate Cancer, and APO010 …
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment